Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review
Authors
Keywords
glomerulonephritis, immunosuppression, pathogenesis, antibodies
Journal
AMERICAN JOURNAL OF KIDNEY DISEASES
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-09-09
DOI
10.1053/j.ajkd.2021.07.019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Patients with Membranous Lupus Nephritis, Exostosin-Positivity and Exostosin-Negativity Represent Two Different Phenotypes
- (2021) Aishwarya Ravindran et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits
- (2021) Ladan Zand et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial
- (2021) Francesco Scolari et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Avacopan for the Treatment of ANCA-Associated Vasculitis
- (2021) David R.W. Jayne et al. NEW ENGLAND JOURNAL OF MEDICINE
- Advances in Membranous Nephropathy
- (2021) Pierre Ronco et al. Journal of Clinical Medicine
- Laminin-521 is a Novel Target of Autoantibodies Associated with Lung Hemorrhage in Anti-GBM Disease
- (2021) Cong-rong Shen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
- (2020) Eric Rondeau et al. KIDNEY INTERNATIONAL
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
- (2020) Michael Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis
- (2020) Jingyuan Xie et al. Nature Communications
- Podocyte Antigen Staining to Identify Distinct Phenotypes and Outcomes in Membranous Nephropathy: A Retrospective Multicenter Cohort Study
- (2020) Nicolas Hanset et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
- (2020) Pierre Charles et al. ANNALS OF INTERNAL MEDICINE
- Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
- (2020) Rona M Smith et al. ANNALS OF THE RHEUMATIC DISEASES
- Randomized Trial Comparing Double Versus Triple Bortezomib-Based Regimen in Patients With Multiple Myeloma and Acute Kidney Injury Due to Cast Nephropathy
- (2020) Frank Bridoux et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis
- (2020) Andrea Angeletti et al. JOURNAL OF EXPERIMENTAL MEDICINE
- LB004A RANDOMIZED, CONTROLLED TRIAL OF RITUXIMAB VERSUS AZATHIOPRINE AFTER INDUCTION OF REMISSION WITH RITUXIMAB FOR PATIENTS WITH ANCA-ASSOCIATED VASCULITIS AND RELAPSING DISEASE
- (2020) Rona Smith et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- CALIBRATE: A Phase 2 Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
- (2020) Yemil Atisha‐Fregoso et al. Arthritis & Rheumatology
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
- (2020) Richard Furie et al. NEW ENGLAND JOURNAL OF MEDICINE
- ANCA-associated vasculitis
- (2020) A. Richard Kitching et al. Nature Reviews Disease Primers
- Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial
- (2019) Rachel B Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy
- (2019) Shigeo Hara et al. VIRCHOWS ARCHIV
- High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial
- (2019) Colin A Hutchison et al. Lancet Haematology
- Immunoglobulin light chains generate proinflammatory and profibrotic kidney injury
- (2019) Wei-Zhong Ying et al. JOURNAL OF CLINICAL INVESTIGATION
- Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
- (2019) Fernando C. Fervenza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations
- (2019) Fernando Corvillo et al. Frontiers in Immunology
- Daratumumab is effective in the relapsed or refractory systemic light‐chain amyloidosis but associated with high infection burden in a frail real‐life population
- (2019) Zoe Van de Wyngaert et al. BRITISH JOURNAL OF HAEMATOLOGY
- Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy
- (2018) Moglie Le Quintrec et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Aliskiren inhibits renin-mediated complement activation
- (2018) Zivile D. Békássy et al. KIDNEY INTERNATIONAL
- C3 glomerulopathy associated with monoclonal Ig is a distinct subtype
- (2018) Aishwarya Ravindran et al. KIDNEY INTERNATIONAL
- A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits
- (2018) Ramnika Gumber et al. KIDNEY INTERNATIONAL
- An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN
- (2018) Song Ren et al. RENAL FAILURE
- Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study
- (2018) Florent Joly et al. BLOOD
- A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis
- (2018) Brad H. Rovin et al. KIDNEY INTERNATIONAL
- Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN
- (2018) Roberta Donadelli et al. Frontiers in Immunology
- Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy
- (2018) Sophie Chauvet et al. Frontiers in Immunology
- Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy
- (2017) Frank Bridoux et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy
- (2017) Jicheng Lv et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients
- (2017) Stephen P. McAdoo et al. KIDNEY INTERNATIONAL
- IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation
- (2017) Stanley C. Jordan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
- (2017) Venkat Reddy et al. RHEUMATOLOGY
- Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
- (2016) Karine Dahan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effectiveness of mycophenolate mofetil in C3 glomerulonephritis
- (2015) Cristina Rabasco et al. KIDNEY INTERNATIONAL
- Intensive Supportive Care plus Immunosuppression in IgA Nephropathy
- (2015) Thomas Rauen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
- (2014) Loïc Guillevin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials
- (2014) J. Robson et al. RHEUMATOLOGY
- Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis
- (2013) Kirsten de Groot ANNALS OF INTERNAL MEDICINE
- Antineutrophil cytoplasm antibody–associated vasculitis: recent developments
- (2013) Shunsuke Furuta et al. KIDNEY INTERNATIONAL
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Lymphopenia and Treatment-Related Infectious Complications in ANCA-Associated Vasculitis
- (2012) R. Goupil et al. Clinical Journal of the American Society of Nephrology
- Endothelium-Neutrophil Interactions in ANCA-Associated Diseases
- (2012) L. Halbwachs et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
- (2012) Bevra H. Hahn et al. ARTHRITIS CARE & RESEARCH
- Pivotal Role of Apoptosis Signal-Regulating Kinase 1 in Monoclonal Free Light Chain–Mediated Apoptosis
- (2011) Wei-Zhong Ying et al. AMERICAN JOURNAL OF PATHOLOGY
- Glucocorticoids and Relapse and Infection Rates in Anti-Neutrophil Cytoplasmic Antibody Disease
- (2011) J. G. McGregor et al. Clinical Journal of the American Society of Nephrology
- Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
- (2011) Mary Anne Dooley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysis
- (2010) Michael Walsh et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
- (2010) F. A. Houssiau et al. ANNALS OF THE RHEUMATIC DISEASES
- Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
- (2010) Thomas F. Hiemstra et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes
- (2010) R. Yang et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Architecture of the Goodpasture Autoantigen in Anti-GBM Nephritis
- (2010) Vadim Pedchenko et al. NEW ENGLAND JOURNAL OF MEDICINE
- Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort
- (2009) Guillermo J. Pons-Estel et al. ARTHRITIS AND RHEUMATISM
- Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
- (2009) G. B. Appel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy
- (2009) Laurence H. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients
- (2008) C Charlier et al. ANNALS OF THE RHEUMATIC DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started